Missed opportunity: PROMs as primary endpoints in bladder cancer trials. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text ...
Background: According to GLOBOCAN, in 2020 there were 573 000 new BC cases and predictions show a significant increase in BC cases from 2020 to 2040 especially in developing countries. This ...